Hangeoreum: A Self-Paced Web-Based Program for Loneliness and Connectedness Among Korean Immigrants Aged 50 and Older
Public ClinicalTrials.gov record NCT07917013. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Hangeoreum Program: A Pilot Study of a Self-Paced, Web-Based Program to Address Loneliness and Connectedness Among Korean Immigrants Aged 50 and Older
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The goal of this clinical trial is to learn whether Hangeoreum, a culturally tailored, self-paced, web-based program, is feasible and acceptable for Korean immigrants aged 50 and older who experience loneliness, and whether participants report improvements in loneliness and other aspects of psychosocial well-being after using the program. Hangeoreum is based on acceptance and commitment therapy (ACT), which teaches practical skills to help people respond to difficult thoughts and feelings while taking meaningful actions guided by their personal values. The main questions this study aims to answer are: * Can participants complete the Hangeoreum program as planned? * Is the program feasible, acceptable, appropriate, and easy to use? * Do participants show reductions in loneliness and improvements in social connectedness and other psychosocial outcomes after completing the program? * What are participants' experiences with the program, and what suggestions do they have for improving it? Participants will: * Complete six self-paced weekly online modules over approximately 6-7 weeks. * Complete online questionnaires before starting and after completing the program. * Take part in one online interview about their experiences with the program.
Study identification
- NCT ID
- NCT07917013
- Recruitment status
- Not yet recruiting
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 40 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 50 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 2026 (Estimated)
- Primary completion
- Apr 2027 (Estimated)
- Completion
- Apr 2027 (Estimated)
- Last update posted
- Nov 4, 2026
2026 – 2027
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of South Florida | Tampa | Florida | 33612 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07917013, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 4, 2026 · Synced Nov 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT07917013 live on ClinicalTrials.gov.